CIK: 0001381843 · Show all filings
Period: Q3 2016 (← Previous) (Next →)
Filing Date: Oct 24, 2016
Total Value ($000): $134,381 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CAH | CARDINAL HEALTH INC | 230,800 | $17,933 | 13.3% | $60.64 | +1.4% | COM | 14149Y108 |
| COR | AMERISOURCEBERGEN CORP | 212,000 | $17,125 | 12.7% | $60.96 | +5.4% | COM | 03073E105 |
| ELV | ANTHEM INC | 135,900 | $17,030 | 12.7% | $117.97 | -3.6% | COM | 036752103 |
| — | INC RESH HLDGS INC | 222,875 | $9,936 | 7.4% | $41.21 | — | CL A | 45329R109 |
| CRL | CHARLES RIV LABS INTL INC | 118,612 | $9,885 | 7.4% | $63.72 | +31.6% | COM | 159864107 |
| — | GNC HLDGS INC | 482,955 | $9,862 | 7.3% | $30.08 | — | COM CL A | 36191G107 |
| MRK | MERCK & CO INC | 157,100 | $9,805 | 7.3% | $36.03 | +21.4% | COM | 58933Y105 |
| ANIK | ANIKA THERAPEUTICS INC | 203,493 | $9,737 | 7.2% | $38.50 | +28.3% | COM | 035255108 |
| — | TRIPLE-S MGMT CORP | 429,904 | $9,428 | 7.0% | $19.84 | — | CL B | 896749108 |
| — | TARO PHARMACEUTICAL INDS LTD | 85,205 | $9,416 | 7.0% | $143.25 | — | SHS | M8737E108 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 379,533 | $9,386 | 7.0% | $17.80 | +27.2% | COM | 868459108 |
| — | PROGENICS PHARMACEUTICALS IN | 280,000 | $1,772 | 1.3% | $6.33 | — | COM | 743187106 |
| ICCC | IMMUCELL CORP | 168,323 | $1,301 | 1.0% | $5.29 | +37.5% | COM PAR $0.10 | 452525306 |
| — | SPDR SERIES TRUST | 20,000 | $915 | 0.7% | $45.75 | — | BRCLYS 1-3MT ETF | 78464A680 |
| SHY | ISHARES TR | 10,000 | $850 | 0.6% | $85.00 | — | 1-3 YR TR BD ETF | 464287457 |